OBJECTIVE: To compare the effects of low-level facility-based interventions on patient retention rates for cardiovascular (CV) disease in an environment of task shifting and nurse-led care in rural health districts in Central Cameroon. METHODS: This study is an open-label, three-arm, cluster-randomised trial in nurse-led facilities. All three groups implemented a treatment contract. The control group (group 1) had no additional intervention, group 2 received the incentive of 1 month of free treatment every forth month of regularly respected visits, and group 3 received reminder letters in case of a missed follow-up visit. The primary outcome was patient retention at 1 year. Secondary outcomes were adherence to follow-up visit schemes and changes in blood pressure (BP) and blood glucose levels. Patients' monthly spending for drugs and transport was calculated retrospectively. RESULTS:A total of 33 centres and 221 patients were included. After 1 year, 109 patients (49.3%) remained in the programme. Retention rates in groups 2 and 3 were 60% and 65%, respectively, against 29% in the control group. The differences between the intervention groups and the control group were significant (P < 0.001), but differences between the two intervention groups were not (P = 0.719). There were no significant differences in BP or fasting plasma glucose trends between retained patients in the study groups. Average monthly cost to patients for antihypertensive medication was € 1.1 ± 0.9 and for diabetics €1.2 ± 1.1. Transport costs to the centres were on average €1.1 ± 1.0 for hypertensive patients and €1.1 ± 1.6 for patients with diabetes. CONCLUSIONS: Low-cost interventions suited to an environment of task shifting and nurse-led care and needing minimal additional resources can significantly improve retention rates in CV disease management in rural Africa. The combination of a treatment contract and reminder letters in case of missed appointments was an effective measure to retain patients in care.
RCT Entities:
OBJECTIVE: To compare the effects of low-level facility-based interventions on patient retention rates for cardiovascular (CV) disease in an environment of task shifting and nurse-led care in rural health districts in Central Cameroon. METHODS: This study is an open-label, three-arm, cluster-randomised trial in nurse-led facilities. All three groups implemented a treatment contract. The control group (group 1) had no additional intervention, group 2 received the incentive of 1 month of free treatment every forth month of regularly respected visits, and group 3 received reminder letters in case of a missed follow-up visit. The primary outcome was patient retention at 1 year. Secondary outcomes were adherence to follow-up visit schemes and changes in blood pressure (BP) and blood glucose levels. Patients' monthly spending for drugs and transport was calculated retrospectively. RESULTS: A total of 33 centres and 221 patients were included. After 1 year, 109 patients (49.3%) remained in the programme. Retention rates in groups 2 and 3 were 60% and 65%, respectively, against 29% in the control group. The differences between the intervention groups and the control group were significant (P < 0.001), but differences between the two intervention groups were not (P = 0.719). There were no significant differences in BP or fasting plasma glucose trends between retained patients in the study groups. Average monthly cost to patients for antihypertensive medication was € 1.1 ± 0.9 and for diabetics €1.2 ± 1.1. Transport costs to the centres were on average €1.1 ± 1.0 for hypertensivepatients and €1.1 ± 1.6 for patients with diabetes. CONCLUSIONS: Low-cost interventions suited to an environment of task shifting and nurse-led care and needing minimal additional resources can significantly improve retention rates in CV disease management in rural Africa. The combination of a treatment contract and reminder letters in case of missed appointments was an effective measure to retain patients in care.
Authors: Sonak D Pastakia; Simon M Manyara; Rajesh Vedanthan; Jemima H Kamano; Diana Menya; Benjamin Andama; Cleophas Chesoli; Jeremiah Laktabai Journal: J Gen Intern Med Date: 2016-12-05 Impact factor: 5.128
Authors: Rajesh Vedanthan; Jemima H Kamano; Hana Lee; Benjamin Andama; Gerald S Bloomfield; Allison K DeLong; David Edelman; Eric A Finkelstein; Joseph W Hogan; Carol R Horowitz; Simon Manyara; Diana Menya; Violet Naanyu; Sonak D Pastakia; Thomas W Valente; Cleophas C Wanyonyi; Valentin Fuster Journal: Am Heart J Date: 2017-03-23 Impact factor: 4.749
Authors: Christine Buttorff; Rebecca S Hock; Helen A Weiss; Smita Naik; Ricardo Araya; Betty R Kirkwood; Daniel Chisholm; Vikram Patel Journal: Bull World Health Organ Date: 2012-09-14 Impact factor: 9.408
Authors: Prashant Kotwani; Laura Balzer; Dalsone Kwarisiima; Tamara D Clark; Jane Kabami; Dathan Byonanebye; Bob Bainomujuni; Douglas Black; Gabriel Chamie; Vivek Jain; Harsha Thirumurthy; Moses R Kamya; Elvin H Geng; Maya L Petersen; Diane V Havlir; Edwin D Charlebois Journal: Trop Med Int Health Date: 2014-02-03 Impact factor: 2.622
Authors: Y Mamo; T Dukessa; A Mortimore; D Dee; A Luintel; I Fordham; D I W Phillips; E H O Parry; D Levene Journal: Public Health Action Date: 2019-09-21
Authors: Anastase Dzudie; André Pascal Kengne; Walinjom F T Muna; Hamadou Ba; Alain Menanga; Charles Kouam Kouam; Joseph Abah; Yves Monkam; Christian Biholong; Pierre Mintom; Félicité Kamdem; Armel Djomou; Jules Ndjebet; Cyrille Wambo; Henry Luma; Kathleen Blackett Ngu; Samuel Kingue Journal: BMJ Open Date: 2012-08-24 Impact factor: 2.692
Authors: Joseph Linju Maria; T N Anand; Boban Dona; Jose Prinu; Dorairaj Prabhakaran; Panniyammakal Jeemon Journal: Lancet Glob Health Date: 2020-11-23 Impact factor: 26.763